However, later studies showed a positive correlation of BMP5 down-regulation with lower relapse-free survival in breast cancer patients and can be used as a therapeutic strategy combined with TGFβ1 to reduce cellular proliferation [20,21]. Here, TGFB1 is linked to breast cancer.